Let's be Blunt with Montel

This week on Let’s Be Blunt with Montel, we’re diving deep into the world of medical cannabis advocacy with a true pioneer, Steph Sherer. As the founder, Board President, and Executive Director of Americans for Safe Access (ASA), Steph has spent over two decades championing patient rights, shaping policy, and driving progress in the medical cannabis movement. In this two-part conversation, Montel and Steph explore her journey from founding ASA in 2002 to leading groundbreaking advocacy campaigns that have transformed the landscape of medical cannabis in the U.S. and beyond. From tackling federal barriers and shaping international drug policy to ASA’s “second act” of integrating cannabis-based medicines into the U.S. healthcare system, Steph shares her unparalleled insights and experiences. Part 1 delves into the origins of ASA, the challenges of early advocacy, and the organization’s most significant achievements over the past 20 years. Steph also breaks down the potential impact of new hemp regulations and what they mean for patients and businesses. This is a must-listen for anyone passionate about patient rights, cannabis policy, and the future of medical cannabis. Tune in to hear Steph’s incredible journey and learn how you can get involved in the fight for safe and legal access to cannabis-based medicine.

On this episode of Let’s Be Blunt with Montel, Montel sits down with award-winning journalist, best-selling author, and cannabis industry pioneer, David Downs. With over a decade of experience on the cannabis beat, David has shaped the way we understand the plant and its industry. From his groundbreaking reporting on vape safety—cited by the CDC and the New England Journal of Medicine—to his best-selling book Marijuana Harvest, David’s work has left an indelible mark on cannabis journalism. David shares insights into his latest venture, the Terpnami SF Seed Show, a celebration of cannabis genetics and culture, and discusses the evolving landscape of hemp regulations, cannabis legalization, and the future of the industry. He also reflects on his career highlights, including writing for iconic publications like Rolling Stone, Scientific American, and The San Francisco Chronicle, and offers advice for aspiring cannabis journalists. Tune in for an engaging conversation about cannabis science, industry trends, and the power of community events like Terpnami. Whether you’re a seasoned cannabis enthusiast or just curious about the plant, this episode is packed with knowledge, inspiration, and a whole lot of passion. Don’t miss it!

On this episode of Let’s Be Blunt with Montel, we’re heading to the southern tip of Africa to explore the dynamic and evolving cannabis landscape in South Africa. Montel sits down with George Joubert, founder of Flourish Cannabis and a trailblazer in the South African cannabis industry. George shares his mission to empower marginalized communities, preserve Africa’s legendary landrace strains, and unlock the vast potential of cannabis for economic and social transformation. From the groundbreaking Cannabis for Private Purposes Bill to the challenges of racism, corporate greed, and global double standards, George provides an unfiltered look at the hurdles and opportunities facing South Africa’s cannabis industry. He also dives into the rich history and cultural significance of cannabis in South Africa, the untapped potential of hemp in sustainable industries, and the unique attributes of African landrace strains that make them a global treasure. Whether you’re curious about cannabis tourism, the role of education in combating stigma, or how small-scale farmers can thrive in this burgeoning market, this episode is packed with insights and inspiration. Tune in to hear how George and Flourish Cannabis are paving the way for a greener, more inclusive future in South Africa. Don’t miss this fascinating conversation—subscribe now and stay blunt!

In this episode of Let’s Be Blunt with Montel, we’re diving into the latest cannabis and hemp news that’s making waves across the industry. From the controversial new federal hemp regulations that could reshape the market to groundbreaking health studies showing the cognitive benefits of cannabis use in older adults, we’ve got it all covered. We’ll also explore the Trump administration’s potential move to reclassify marijuana as a Schedule III drug, the Supreme Court case that could set a precedent for CBD product labeling, and the ongoing battle over hemp-THC regulations in states like Ohio, Missouri, and Minnesota. Plus, we’ll break down the latest business updates, including major moves from companies like Trulieve, Curaleaf, and Canopy Growth. On a personal note, Montel shares how the latest health research hits close to home, as it highlights the long-term cognitive benefits of cannabis use—something he’s experienced firsthand over the past 25 years. Finally, we want to hear from YOU! Share your thoughts on the new hemp regulations, state-level legalization efforts, or your own cannabis journey. Your feedback could be featured in a future episode. Tune in for an informative, engaging, and empowering discussion that keeps you in the know about all things cannabis. Key Topics Covered: Federal hemp regulations and their potential impact Health studies on cannabis and cognitive performance in older adults State-level legalization updates in Virginia, Ohio, and Minnesota Business highlights from Trulieve, Curaleaf, and more The Supreme Court case on CBD product labeling Stay informed, stay empowered, and stay blunt!

On this episode of Let’s Be Blunt with Montel, we’re diving deep into the world of cannabis disinformation with strategic communications and media analyst, Madicyn Marinaro. Madicyn has dedicated her career to uncovering the patterns, tactics, and financial incentives behind fear-based narratives that echo the propaganda of Reefer Madness. From debunking myths about cannabis hyperemesis syndrome (CHS) and psychosis to exposing how platform algorithms amplify disinformation, Madicyn sheds light on the forces shaping public perception and the cannabis industry itself. Join Montel and Madicyn as they explore the intersection of media ethics, policy, and the fight for evidence-based communication in a space long constrained by stigma and misinformation. Whether you’re a cannabis advocate, industry professional, or simply curious about the truth behind the headlines, this episode is packed with insights you won’t want to miss. Let’s cut through the noise and get blunt about cannabis disinformation. 🌿